In this slide deck, we address some of the key questions about what makes Lp(a) such an important risk factor for atherosclerotic cardiovascular disease and aortic valve stenosis, including the impact of apo(a) isoform size on Lp(a) concentration, and the role of Lp(a) as a major carrier of proinflammatory oxidised phospholipids.
Lilly has provided arms’ length sponsorship funding for the Lp(a) Forum Back to Basics Educational Resources but has had no influence or control over the content.
